The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy
Zhongsong Zhang, Chao Chang, Lifan Xiao, Hang Su, Yaping Lyu, Junxian Zhao, Junhao Chen, Keyi Gou, Jingfeng Zhou, Chengjie Wang, Xingcheng Zhu, Shi Fu, Mao Lu, Lei Shi · 2025
Read The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy by Zhongsong Zhang, Chao Chang, Lifan Xiao, Hang Su, Yaping Lyu, Junxian Zhao, Junhao Chen, Keyi Gou, Jingfeng Zhou, Chengjie Wang, Xingcheng Zhu, Shi Fu, Mao Lu, Lei Shi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12746843.txt.
Description
Atopic dermatitis, the itchy skin disease also called eczema, is driven by a tangled loop between nerves and the immune system. Zhongsong Zhang led a team reviewing how that loop works and how new treatments aim at it. Signals such as IL-31 and IL-4 talk both ways between skin, nerves, and brain, feeding the itch-scratch cycle that keeps the disease alive.
Fresh tools, from single-cell mapping to brain imaging and gut microbe profiling, are redrawing the map of these nerve-immune neighborhoods. The review gathers markers that could sort patients and track treatment, then surveys drugs old and new, from pathway blockers to microbe-based care. The authors argue that aiming at the nerve-immune axis could bring steadier, better-matched therapy.
Catalog record
| CREATOR | Zhongsong Zhang, Chao Chang, Lifan Xiao, Hang Su, Yaping Lyu, Junxian Zhao, Junhao Chen, Keyi Gou, Jingfeng Zhou, Chengjie Wang, Xingcheng Zhu, Shi Fu, Mao Lu, Lei Shi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 129 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |